Effectiveness of metformin and lifestyle interventions as an initial treatment in japanese patients with newly diagnosed type 2 diabetes: A prospective observational study

Journal of Medical Investigation

Volumn 59, Issue 1-2, 2012, Pages 166-173

  Sumitani, Satoru ^a   Morita, Shinya ^a   Utsu, Yoshihiko ^a   Mukai, Kosuke ^a   Miki, Shunji ^a   Sato, Bunzo ^a   Nakamura, Hideji ^a   Kasayama, Soji ^a  

^a NISSAY HOSPITAL   (Japan)

Author keywords

Hypoglycemia; Lifestyle interventions; Management; Metformin; Type 2 diabetes

Indexed keywords

CHOLESTEROL; CYANOCOBALAMIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN;

ABDOMINAL DISCOMFORT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIET THERAPY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; JAPANESE; LACTIC ACIDOSIS; LIFESTYLE MODIFICATION; MALE; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PHYSICAL ACTIVITY; PROSPECTIVE STUDY; SIDE EFFECT; THERAPY EFFECT; VITAMIN BLOOD LEVEL;

EID: 84857672549     PISSN: 13431420     EISSN: None     Source Type: Journal    
DOI: 10.2152/jmi.59.166     Document Type: Article

References (28)

1. UK Prospective Diabetes Study (UKPDS) Group: Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS34). Lancet 352: 854-865, 1998
2. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HW: 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359: 1577-1589, 2008
3. Donnelly LA, Doney ASF, Hattersley AT, Morris AD, Pearson ER: The effect of obesity on glycaemic response to metformin or sulfonylureas in type 2 diabetes. Diabetic Med 23: 128-133, 2006
4. Kaku K, Tajima N, Kawamori R: Melbin Observational Research (MORE) study of metformin therapy in patients with type 2 diabetes. J Japan Diab Soc 49: 325-331, 2006 (in Japanese)
5. Hosokawa K, Meguro S, Funae O, Murata C, Katou K, Mokubo A, Suzuki Y, Anazawa S, Atsumi Y, Matsuoka K: Clinical effects of metformin in patients with nonobese type 2 diabetes. J Japan Diab Soc 52: 1-6, 2009 (in Japanese)
6. IDF Clinical Guidelines Task Force: Global guideline for Type 2 diabetes. Brussels: International Diabetes Federation, 2005
7. Chan JCN, Deerochanawong C, Shera AS, Yoon KH, Adam JMF, Binh TV, Chan SP, Fernando RE, Horn LC, Khue NT, Litonjua AD, Soegondo S, Zimmet P: Role of metformin in the initiation of pharmacotherapy for type 2 diabetes: an Asian-Pacific perspective. Diabetes Res Clin Pract 75: 255-266, 2007
8. Garber AJ, Duncan TG, Goodman AM, Mills DJ, Rohlf JL: Efficacy of metformin in Type II diabetes: Results of a double-blind, placebocontrolled, dose-response trial. Am J Med 102: 491-497, 1997
9. Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, Zinman B: Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation andadjustment of therapy. Diabetes Care 29: 1963-1972, 2006
10. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B: Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetes Care 32: 193-203, 2009
11. Scarpello JH: Optimal dosing strategies for maximising the clinical response to metformin in type 2 diabetes. Br J Diabetes Vasc Dis 1: 28-36, 2001
12. World Health Organization: Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: Diagnosis and classification of diabetes mellitus. Geneva, World Health Organization, 1999
13. Gillespie SJ, Kulkarni KD, Daly AE: Using carbohydrate counting in diabetes clinical practice. J Am Diet Assoc 98: 897-905, 1998
14. Franz MJ, Bantle JP, Beebe CA, Brunzell JD, Chiasson JL, Garg A, Holzmeister LA, Hoogwerf B, Mayer-Davis E, Mooradian AD, Purnell J, Wheeler M: Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care 25: 148-198, 2002
15. American Diabetes Association: Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 30: S48-S65, 2007
16. Kirk JK, Graves DE, Craven TE, Lipkin EW, Austin M, Margolis KL: Restricted-carbohydrate diets in patients with type 2 diabetes: a meta-analysis. J Am Diet Assoc 108: 91-100, 2008
17. Dali-Youcef N, Andres E: An update on cobalamin deficiency in adults. Q J Med 102: 17-28, 2009
18. The Committee of Japan Diabetes Society on the diagnostic criteria of diabetes mellitus: Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Invest 1: 212-228, 2010
19. Friedwald WT, Levy RI, Friedrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502, 1972
20. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata H, Hishida A: Revised equations for estimated GFR from serum creatinine in Japan. Am J Kid Dis 53: 982-992, 2009
21. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA: A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 17: 1281-1289, 1994
22. Saito R, Ishii H, Morioka K, Matsumoto M: Efficacy of high-dose metformin in type 2 diabetes. J Japan Diab Soc 46: 399-402, 2003 (in Japanese)
23. DeFronzo RA, Goodman AM, the Multicenter Metformin Study Group: Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 333: 541-549, 1995
24. DeFronzo RA, Ferrannini E, Simonson DC: Fasting hyperglycemia in non-insulin dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 38: 387-395, 1989
25. Inzucchi SE: Oral hypoglycemic therapy for type 2 diabetes. JAMA 287: 360-372, 2002
26. de Jager J, Kooy A, Lehert P, Wulffele MG, van del Kolk J, Bets D, Verburg J, Donker AJ, Stehouwer CD: Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomized placebo-controlled trial. BMJ 340: c2181 doi: 10.1136/bmj.c2181, 2010
27. Bailey CJ, Turner RC: Metformin. N Engl J Med 334: 574-579, 1996
28. Bailey CJ, Howlett HC: Tolerability of metformin. In: Bailey CJ, Campbell JW, Chan JCN, Davidson JA, Howlett HC, Ritz P, eds. Metformin The gold standard. John Wiley and Sons Ltd, Chichester, 2007, pp.173-178.